Thymagen: research, legal status and who sells it
This page is information, not medical advice. Thymagen is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- Thymogen, Glu-Trp, EW peptide
- Category
- Synthetic dipeptide (Glu-Trp) registered as a medicine in Russia under the name Thymogen
- Evidence level
- Early human trials
- Price range
- $3.40/mg to $5.95/mg, median $4.00/mg across 6 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains thymagen (Thymogen) [1]. |
| United Kingdom | No UK-licensed medicine containing thymagen (Thymogen) appears in the MHRA products database [2]. |
| European Union | No medicine containing thymagen (Thymogen) is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing thymagen (Thymogen) appears in Health Canada's Drug Product Database [5]. |
| Australia | Thymagen (Thymogen) is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List [7]. |
We haven't published a full overview of Thymagen yet. The legal status table and live prices on this page are current.
Thymagen prices: cheapest listings
The five lowest $/mg listings out of 6. See all Thymagen prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Peptide Crafters | 27 | 25 mg | $70 | $2.80/mg | Out of stock | View | |
| Swiss Chems FDA warning letter, Dec 2024 | 72 | 20 mg | $68 | $3.40/mg | View | ||
| Pure Lab Peptides | 82 | 20 mg | $70 | $3.50/mg | View | ||
| Peptides World | 80 | 20 mg | $80 | $4.00/mg | View | ||
| BioLongevity Labs | 72 | 20 mg | $80 | $4.00/mg | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "thymogen". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- The First Reciprocal Activities of Chiral Peptide Pharmaceuticals: Thymogen and Thymodepressin, as Examples. International Journal of Molecular Sciences (2024). Accessed Oct 15, 2026
- Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line. International Journal of Molecular Sciences (2022). Accessed Oct 15, 2026